drugset / Trial / NCT02153840

Clinical Trial of PSORI-CM01(YXBCM01) Granule to Treat Stable Plaque Psoriasis

NCT02153840 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Chinese herbal PSORI-CM01(YXBCM01) granule for stable plaque psoriasis, with blood stasis syndrome of Chinese Medicine.

Timeline

Start
2013-12
Primary completion
2014-11
Completion
2015-10

Outcome

Outcome not reported

Stopped: “Paitents were unwilling to be randomly assigned to a placebo group.”

Drugs

EvaluationDrugModalityDoseRoute
Subject PSORI-CM01(YXBCM01) Traditional medicine (herbal / TCM) 1.1 g Other
Subject PSORI-CM01(YXBCM01) Traditional medicine (herbal / TCM) 5.5 g Other

Indications